INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 18, 2009 |
VP Regul Devel & Med Safety
Trans History: 288
|
VP Regul Devel & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 23,795 | -- | 23,795 |
| Nov 17, 2014 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 23,810 | $401.75 | 42,391 |
| Aug 23, 2017 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 23,872 | $479.45 | 23,689,302 |
| Mar 07, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 23,881 | $334.09 | 17,351,227 |
| Nov 22, 2019 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 23,989 | $358.33 | 362,727 |
| Oct 31, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 24,000 | $8.62 | 27,574 |
| Oct 31, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Open market or private sale of non-derivative or derivative security | 24,000 | $20.00 | 3,574 |
| Oct 31, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 24,000 | -- | -- |
| Feb 03, 2006 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 24,000 | $7.41 | 27,127 |
| Feb 03, 2006 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 24,000 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.